文献速递腹部泌尿生殖技术与安全CT

「碘衍生灌注」模型应用于高动脉血供腹部组织:胰腺、肾皮质与肝细胞癌

The "iodine-derived perfusion" model applied to abdominal tissues with high arterial vascularization: pancreas, kidney cortex, and hepatocellular carcinoma.
PubMed 文献 · Br J Radiol · 2026-01-01

回顾性分析11例肝细胞癌患者的CT灌注扫描(每1.5秒一帧,共40帧),在主动脉、肝细胞癌、胰腺和肾皮质勾画感兴趣区,比较最大斜率法与基于团注末期碘量的「碘衍生灌注」法。两种方法所得灌注值无显著差异(P=0.92),碘衍生灌注与最大斜率法灌注相关(r²=0.82,P≤0.001)。肾皮质灌注高于肝细胞癌和胰腺(P≤0.001)。

要点

  • 碘衍生灌注与最大斜率法灌注线性相关:碘衍生灌注(mL/s/mL)=0.57+0.8×最大斜率法灌注(r²=0.82,P≤0.001)。
  • 肝细胞癌、胰腺、肾皮质的碘衍生灌注分别为1.5±0.3、1.4±0.5、2.7±0.3 mL/s/mL,最大斜率法分别为1.1±0.56、1.3±0.65、3.1±0.91 mL/s/mL。
  • 肾皮质灌注高于肝细胞癌和胰腺(P≤0.001)。

核心结论

  • 晚期动脉期组织强化与最大斜率法计算的器官灌注密切相关。
  • 晚期动脉期强化是器官灌注的替代指标;若考虑注射碘量或估算心输出量,可定量表达。

研究设计与样本

  • 回顾性分析11例肝细胞癌患者(年龄69±9岁,8例男性)的CT灌注扫描,每1.5秒一帧,共40帧。
  • 在主动脉、肝细胞癌、胰腺和肾皮质勾画感兴趣区。
  • 灌注计算采用两种方法:强化-时间最大斜率法;基于团注末期碘量(大部分对比剂位于血管外间隙时)的碘衍生灌注法。

关键影像表现/征象

  • 原文未涉及影像征象描述。

诊断标准与关键数值

  • 碘衍生灌注(mL/s/mL)=0.57+0.8×最大斜率法灌注(r²=0.82,P≤0.001),Bland-Altman偏倚-0.01。
  • 肝细胞癌碘衍生灌注1.5±0.3 mL/s/mL,最大斜率法灌注1.1±0.56 mL/s/mL。
  • 胰腺碘衍生灌注1.4±0.5 mL/s/mL,最大斜率法灌注1.3±0.65 mL/s/mL。
  • 肾皮质碘衍生灌注2.7±0.3 mL/s/mL,最大斜率法灌注3.1±0.91 mL/s/mL。
  • 两种方法结果无显著差异(P=0.92);肾皮质灌注高于肝细胞癌和胰腺(P≤0.001)。

临床应用与阅片要点

  • 晚期动脉期强化可作为器官灌注的替代指标,若考虑注射碘量或估算心输出量,可定量表达为碘衍生灌注。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

OBJECTIVES: We investigated the relationship between enhancement and perfusion of abdominal tissues with high arterial vascularization, testing the hypothesis that in pancreas, kidney cortex, and HCC the iodine accumulated be proportional to the fraction of cardiac output (CO).

METHODS: Computed tomography perfusion scans (every 1.5 s, 40 frames) of 11 patients with HCC (aged 69 ± 9 years, 8 males) were retrospectively analysed. Regions of interest (ROIs) were drawn on aorta, HCC, pancreas, and kidney cortex. Perfusion was computed: (1) using the enhancement-to-time maximum slope (MS) method; and (2) based on the amount of iodine at the end of the bolus, when most of contrast is in the extravascular compartment. Consequently, the amount of iodine divided by total iodine injected represents the CO fraction perfusing the tissue encompassed by the ROI; this value multiplied by CO gives the "iodine-derived perfusion" as blood volume per unit of volume per unit of time.

RESULTS: Values of iodine-derived perfusion was related with that computed from the MS method: iodine-derived perfusion (mL/s/mL) = 0.57 + 0.8 × MS perfusion (r2 = 0.82, P ≤ .001, Bland-Altman bias -0.01). Iodine-derived perfusion was 1.5 ± 0.3, 1.4 ± 0.5, and 2.7 ± 0.3 mL/s/mL while MS-derived perfusion was 1.1 ± 0.56, 1.3 ± 0.65, and 3.1 ± 0.91 mL/s/mL for HCC, pancreas, and kidney cortex, respectively. The results from the 2 methods were not different (P = .92). Kidney cortex perfusion was greater than those of HCC and pancreas (P ≤ .001).

CONCLUSIONS: Tissue enhancement in late arterial phase is well related to organ perfusion computed with the MS method.

ADVANCES IN KNOWLEDGE: CE in late arterial phase is a proxy for organ perfusion and can be expressed quantitatively if the amount of iodine injected is considered or cardiac output is estimated.

来源:Br J Radiol,查看原文。版权归原作者所有。

引用

  1. Cressoni M, Cina C, Darvizeh F, et al. The "iodine-derived perfusion" model applied to abdominal tissues with high arterial vascularization: pancreas, kidney cortex, and hepatocellular carcinoma. Br J Radiol. 2026. PMID: 41259658. doi:10.1093/bjr/tqaf281

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。